MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT05973669 | COMPLETED | NA
53 participants

MED-EL Remote Care Multi-Center Feasibility Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2024-11-05
Completion:
2026-05-11
Conditions
  • Hearing Loss, Sensorineural
  • Cochlear Implant
  • Cochlear Implant Recipients
  • Hearing Disorders
  • Cochlear Implants
Interventions
  • DEVICE
No Results Yet
NCT05947500 | ACTIVE_NOT_RECRUITING | PHASE2
50 participants

Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2024-05-21
Completion:
2028-01-01
Conditions
  • Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
  • Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8
  • Locally Advanced Merkel Cell Carcinoma
  • Metastatic Merkel Cell Carcinoma
  • Refractory Merkel Cell Carcinoma
  • Unresectable Merkel Cell Carcinoma
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT05913687 | ACTIVE_NOT_RECRUITING
315 participants

Automated Imaging Differentiation of Parkinsonism

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-31
Start Date:
2021-07-22
Completion:
2027-03-31
Conditions
  • Parkinson Disease
  • Multiple System Atrophy, Parkinson Variant
  • Progressive Supranuclear Palsy
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT05833048 | RECRUITING | NA
75 participants

Rectus Sheath Block in Cardiac Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2024-07-29
Completion:
2026-10-30
Conditions
  • Cardiac Disease
  • Postoperative Pain
Interventions
  • PROCEDURE
No Results Yet
NCT05759923 | RECRUITING | PHASE1
40 participants

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2023-01-26
Completion:
2027-03-31
Conditions
  • Advanced Ovarian Carcinoma
  • Advanced Renal Cell Carcinoma
  • Advanced Pancreatic Carcinoma
  • Advanced Colorectal Carcinoma
  • Metastatic Pancreatic Carcinoma
  • Metastatic Colorectal Carcinoma
  • Metastatic Renal Cell Carcinoma
  • Metastatic Ovarian Carcinoma
Interventions
  • DRUG
No Results Yet
NCT05691491 | RECRUITING | PHASE1/PHASE2
42 participants

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2023-09-28
Completion:
2027-03-01
Conditions
  • Advanced Malignant Solid Neoplasm
  • Advanced Microsatellite Stable Colorectal Carcinoma
  • Hematopoietic and Lymphatic System Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Microsatellite Stable Colorectal Carcinoma
  • Stage III Colorectal Cancer AJCC v8
  • Stage IV Colorectal Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT05673551 | ENROLLING_BY_INVITATION | NA
220 participants

VR-PAT During Home Burn Dressings - Multisite

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2023-01-16
Completion:
2027-12-01
Conditions
  • Burns
  • Acute Pain
  • Procedural Pain
  • Injuries
  • Pediatric ALL
Interventions
  • OTHER
No Results Yet
NCT05673200 | SUSPENDED | PHASE1
32 participants

Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2023-09-25
Completion:
2027-02-23
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Carcinoma
  • Unresectable Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page